Planned website maintenance is taking place from 11:00 pm AEDT on Friday 30 October to 6:00 am AEDT on Saturday 31 October 2026. Some pages may be temporarily unavailable. If issues continue outside this time, please contact us.
AusPAR: Keytruda
Device/Product Name
Keytruda
Active ingredients
Pembrolizumab
AusPAR Date
Published
Submission Number
PM-2020-02312-1-6
Submission Type
Extension of indications
Decision
Approved